Amyloid-targeting drugs make up one part of the biology of aging approach and are the first step in developing multiple drugs to treat Alzheimer’s disease NEW YORK, May 3, 2023 /PRNewswire/ — The Alzheimer’s Drug Discovery Foundation (ADDF) is encouraged to see the positive data reported…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.